WO2023012263 - SOLID ORAL PEPTIDE FORMULATIONS
National phase entry is expected:
Publication Number
WO/2023/012263
Publication Date
09.02.2023
International Application No.
PCT/EP2022/071913
International Filing Date
04.08.2022
Title **
[English]
SOLID ORAL PEPTIDE FORMULATIONS
[French]
FORMULATIONS SOLIDES DE PEPTIDES ORAUX
Applicants **
NOVO NORDISK A/S
Inventors
SASSENE, Philip Jonas
BLAABJERG, Lasse
PESSI, Jenni
Priority Data
21189585.9
04.08.2021
EP
21189640.2
04.08.2021
EP
22161506.5
11.03.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2679 | |
| EPO | Filing, Examination, Granting | 11017 | |
| Japan | Filing, Examination, Granting | 2278 | |
| South Korea | Filing, Examination, Granting | 2331 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
23,045
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention provides solid compositions comprising a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and a further absorption enhancer, their method of preparation and use in medicine.[French]
La présente invention concerne des compositions solides comprenant un sel d'acide N-(8-(2-hydroxybenzoyl)amino)caprylique et un autre renforçateur d'absorption, leur procédé de préparation et leur utilisation en médecine.